| Clinical data | |
|---|---|
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 86168-78-7 |
| ATC code | H01AC04 V04CD03 |
| PubChem | CID 16132413 |
| DrugBank | DB00010 |
| UNII | 89243S03TE |
| KEGG | D08509 |
| ChEMBL | CHEMBL1201490 |
| Chemical data | |
| Formula | C149H246N44O42S |
| Mol. mass | 3357.882 |
|
|
| |
|
Sermorelin, sometimes called GRF 1-29, is a growth hormone releasing hormone analogue. It is a 29-amino acid polypeptide representing the 1-29 fragment from endogenous human growth hormone releasing hormone, and is thought to be the shortest fully functional fragment of GHRH.[1] It is used as a test for growth hormone secretion.[2] It is also used as doping substance in sports.[citation needed]
See also [edit]
References [edit]
- ^ Prakash A, Goa KL (August 1999). "Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency". BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy 12 (2): 139–57. PMID 18031173.
- ^ Pharmacology (Rang, Dale, Ritter & Moore, ISBN 0-443-07145-4, 5:th ed., Churchill Livingstone 2003).
|
||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||
| This hormonal preparation article is a stub. You can help Wikipedia by expanding it. |
A portion of the proceeds from advertising on Digplanet goes to supporting Wikipedia.









